Guardant Health (GH) Competitors

$98.29 -0.18 (-0.18%)

As of 02:21 PM Eastern

GH vs. NTRA, FMS, BTSG, HIMS, and CELC

Should you buy Guardant Health stock or one of its competitors? MarketBeat compares Guardant Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardant Health include Natera (NTRA), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does Guardant Health compare to Natera?

Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	12.34	-$208.16M	-$1.63	N/A
Guardant Health	$982.02M	13.21	-$416.28M	-$3.39	N/A

99.9% of Natera shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of Natera shares are held by insiders. Comparatively, 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Natera has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Guardant Health	-40.10%	N/A	-26.42%

Natera presently has a consensus price target of $256.60, suggesting a potential upside of 29.11%. Guardant Health has a consensus price target of $129.42, suggesting a potential upside of 32.31%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.79
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

In the previous week, Natera had 6 more articles in the media than Guardant Health. MarketBeat recorded 32 mentions for Natera and 26 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.56 beat Natera's score of 0.43 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	10 Very Positive mention(s)	5 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Natera beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.36B	0.62	$1.11B	$1.90	11.29
Guardant Health	$982.02M	13.21	-$416.28M	-$3.39	N/A

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Guardant Health	-40.10%	N/A	-26.42%

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, suggesting a potential upside of 30.57%. Guardant Health has a consensus price target of $129.42, suggesting a potential upside of 32.31%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

In the previous week, Guardant Health had 20 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 26 mentions for Guardant Health and 6 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Guardant Health's score of 0.56 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Fresenius Medical Care AG & Co. KGaA and Guardant Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

Guardant Health (NASDAQ:GH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
BrightSpring Health Services	2.27%	14.63%	4.41%

Guardant Health currently has a consensus price target of $129.42, suggesting a potential upside of 32.31%. BrightSpring Health Services has a consensus price target of $56.29, suggesting a potential downside of 3.41%. Given Guardant Health's higher probable upside, research analysts plainly believe Guardant Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Guardant Health had 19 more articles in the media than BrightSpring Health Services. MarketBeat recorded 26 mentions for Guardant Health and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.95 beat Guardant Health's score of 0.56 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	13.21	-$416.28M	-$3.39	N/A
BrightSpring Health Services	$12.91B	0.88	$190.67M	$1.41	41.33

Guardant Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.71, meaning that its stock price is 71% more volatile than the broader market.

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Hims & Hers Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Hims & Hers Health	-0.56%	6.10%	1.52%

Guardant Health currently has a consensus price target of $129.42, suggesting a potential upside of 32.31%. Hims & Hers Health has a consensus price target of $29.50, suggesting a potential upside of 19.76%. Given Guardant Health's stronger consensus rating and higher probable upside, research analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 47 more articles in the media than Guardant Health. MarketBeat recorded 73 mentions for Hims & Hers Health and 26 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.56 beat Hims & Hers Health's score of 0.02 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	16 Very Positive mention(s)	11 Positive mention(s)	9 Neutral mention(s)	24 Negative mention(s)	5 Very Negative mention(s)	Neutral

Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	13.21	-$416.28M	-$3.39	N/A
Hims & Hers Health	$2.35B	2.39	$128.37M	$0.51	48.30

Guardant Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.43, meaning that its stock price is 143% more volatile than the broader market.

Summary

Hims & Hers Health beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Celcuity?

Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Guardant Health has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market.

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Celcuity	N/A	-203.17%	-52.68%

In the previous week, Guardant Health had 19 more articles in the media than Celcuity. MarketBeat recorded 26 mentions for Guardant Health and 7 mentions for Celcuity. Celcuity's average media sentiment score of 1.28 beat Guardant Health's score of 0.56 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Celcuity has lower revenue, but higher earnings than Guardant Health. Celcuity is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	13.21	-$416.28M	-$3.39	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A

Guardant Health currently has a consensus price target of $129.42, suggesting a potential upside of 32.31%. Celcuity has a consensus price target of $134.50, suggesting a potential upside of 1.11%. Given Guardant Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Guardant Health is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 13.3% of Celcuity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Guardant Health beats Celcuity on 11 of the 15 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$12.95B	$3.40B	$6.30B	$12.46B
Dividend Yield	N/A	2.31%	2.79%	5.30%
P/E Ratio	-28.81	18.73	20.92	25.65
Price / Sales	13.21	294.61	551.58	76.73
Price / Cash	N/A	122.51	42.94	55.34
Price / Book	-71.40	6.77	9.87	6.72
Net Income	-$416.28M	$24.11M	$3.55B	$333.73M
7 Day Performance	6.02%	0.05%	-0.20%	0.40%
1 Month Performance	13.21%	0.91%	1.48%	4.09%
1 Year Performance	140.21%	77.69%	41.00%	36.52%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	3.3429 of 5 stars	$98.29 -0.2%	$129.42 +31.7%	+138.1%	$13.02B	$982.02M	N/A	2,506	Analyst Forecast Insider Trade
NTRA Natera	3.6606 of 5 stars	$199.14 +2.5%	$255.33 +28.2%	+28.3%	$27.64B	$2.31B	N/A	6,140	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.8765 of 5 stars	$21.76 -1.2%	$28.00 +28.7%	-23.6%	$12.31B	$22.20B	11.45	1,488
BTSG BrightSpring Health Services	3.5389 of 5 stars	$55.07 +0.4%	$56.29 +2.2%	+143.1%	$10.63B	$12.91B	39.06	23,500
HIMS Hims & Hers Health	4.2909 of 5 stars	$29.12 +3.0%	$31.86 +9.4%	-62.3%	$6.44B	$2.35B	57.10	2,442	Trending News Earnings Report Analyst Forecast Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. NTRA, FMS, BTSG, HIMS, and CELC

How does Guardant Health compare to Natera?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

How does Guardant Health compare to Hims & Hers Health?

Summary

How does Guardant Health compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. NTRA, FMS, BTSG, HIMS, and CELC

How does Guardant Health compare to Natera?

Which has stronger earnings and valuation, NTRA or GH?

Do insiders and institutionals have more ownership in NTRA or GH?

Which has more risk and volatility, NTRA or GH?

Is NTRA or GH more profitable?

Do analysts rate NTRA or GH?

Does the media prefer NTRA or GH?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has stronger earnings and valuation, FMS or GH?

Do insiders and institutionals have more ownership in FMS or GH?

Which has more risk and volatility, FMS or GH?

Is FMS or GH more profitable?

Do analysts rate FMS or GH?

Does the media prefer FMS or GH?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Is GH or BTSG more profitable?

Do analysts prefer GH or BTSG?

Do institutionals and insiders hold more shares of GH or BTSG?

Does the media favor GH or BTSG?

Which has preferable earnings and valuation, GH or BTSG?

Which has more risk and volatility, GH or BTSG?

Summary

How does Guardant Health compare to Hims & Hers Health?

Is GH or HIMS more profitable?

Do analysts prefer GH or HIMS?

Do institutionals and insiders hold more shares of GH or HIMS?

Does the media favor GH or HIMS?

Which has preferable earnings and valuation, GH or HIMS?

Which has more risk and volatility, GH or HIMS?

Summary

How does Guardant Health compare to Celcuity?

Which has more volatility & risk, GH or CELC?

Is GH or CELC more profitable?

Does the media favor GH or CELC?

Which has better valuation & earnings, GH or CELC?

Do analysts prefer GH or CELC?

Do insiders & institutionals hold more shares of GH or CELC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools